Drug-maker Sun Pharmaceutical Industries gained over 3 per cent on the bourses on Monday after the company reported
19 per cent growth in net profit to Rs 598 crore for the quarter ended September 30.
Shares of the company jumped by 3.4 per cent to Rs 521 on the BSE, while on the NSE, the scrip gained 3.5 per cent to Rs 522.
The drug-maker's scrip was also the top gainer among the Sensex-30 blue-chips in morning trade.
Sun Pharmaceutical Industries has reported 19 per cent growth in net profit to Rs 598 crore for the quarter ended September 30 on account of robust performance across its businesses.
In the corresponding year-ago period, the company had posted a net profit of Rs 503.65 crore.
On a standalone basis, Sun Pharma's net profit increased to Rs 437.55 crore in the second quarter ended September 30 from Rs 345.72 crore in the year-ago period.
Disclaimer: Business Today provides stock market news for informational purposes only and should not be construed as investment advice. Readers are encouraged to consult with a qualified financial advisor before making any investment decisions.
Special 
